These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3881119)

  • 1. Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast.
    Benedetto C; Zonca M; Tavella AM; Petitti E; Massobrio M; Nigam S; Slater TF
    Br J Cancer; 1985 Jan; 51(1):49-53. PubMed ID: 3881119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
    Wilson AP; Efthimiou J; Betteridge DJ
    Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual migraine: a possible pathogenic implication of platelet function.
    Benedetto C; Massobrio M; Zonca M; Melzi E; Nattero G; Allais G; Torre E
    Gynecol Endocrinol; 1987 Dec; 1(4):345-53. PubMed ID: 3332539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.
    Gerö G; Rákóczi I; Tihanyi K; Oláh J; Demeter J; Gáti I
    Haemostasis; 1985; 15(6):377-83. PubMed ID: 3908235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic actions of prostacyclin and an isoquinoline derivative (CH-102) on ADP-induced aggregation of dog platelets in vitro.
    Pataricza J; Bor P; Szekeres L
    Biomed Biochim Acta; 1984; 43(12):1365-9. PubMed ID: 6398698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG; Wong T; Frojmovic MM
    Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.
    Davis TM; Bown E; Turner RC
    Diabetologia; 1985 May; 28(5):274-6. PubMed ID: 3894139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet alterations in shear flow: dose response of prostacyclin on human platelets.
    Hung TC; Butter DB; Graham MF; Lewis JH; Zhao JQ; Haubold AD
    Trans Am Soc Artif Intern Organs; 1983; 29():436-41. PubMed ID: 6424310
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet sensitivity to prostacyclin in diabetes mellitus.
    Pillay PK; Pillay U; Balasubramaniam P; Lee KO
    Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD; Knudsen F; Nielsen AH; Ring T
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
    Vicari AM; Macagni A; Pozza G
    Horm Metab Res; 1989 Nov; 21(11):616-8. PubMed ID: 2480323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerobic exercise training lowers platelet reactivity and improves platelet sensitivity to prostacyclin in pre- and postmenopausal women.
    Lundberg Slingsby MH; Nyberg M; Egelund J; Mandrup CM; Frikke-Schmidt R; Kirkby NS; Hellsten Y
    J Thromb Haemost; 2017 Dec; 15(12):2419-2431. PubMed ID: 29027349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased sensitivity of platelets to prostacyclin in patients with diabetes mellitus.
    Akai T; Naka K; Okuda K; Takemura T; Fujii S
    Horm Metab Res; 1983 Nov; 15(11):523-6. PubMed ID: 6360841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
    Wadenvik H; Kutti J
    Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers.
    Yardumian DA; Mackie IJ; Brennan EC; Bull H; Machin SJ
    Haemostasis; 1986; 16(1):20-6. PubMed ID: 2422095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet reactivity in unstable coronary artery disease.
    Swahn E; Wallentin L
    Thromb Haemost; 1987 Jun; 57(3):302-5. PubMed ID: 2958954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.